EPISTEM LIMITED

Active Manchester

Research and experimental development on biotechnology

29 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

EPISTEM LIMITED

Research and experimental development on biotechnology

Founded 25 Oct 2017 Active Manchester, United Kingdom 29 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

EPISTEM 2 LIMITED 25 Oct 2017 — 13 Jun 2018
Accounts Due 30 Sept 2026 5 months remaining
Confirmation Submitted 11 Dec 2025 Next due 7 Nov 2026 6 months remaining
Net assets £-4M £647K 2024 year on year
Total assets £1M £439K 2024 year on year
Total Liabilities £5M £209K 2024 year on year
Charges 3
3 outstanding

Contact & Details

Contact

Registered Address

The Incubator Building Grafton Street Manchester M13 9XX United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for EPISTEM LIMITED (11031998), an active life sciences and medical technology company based in Manchester, United Kingdom. Incorporated 25 Oct 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

£246.32k

Increased by £101.39k (+70%)

Net Assets

-£3.72M

Decreased by £647.39k (-21%)

Total Liabilities

£4.72M

Increased by £208.85k (+5%)

Turnover

N/A

Employees

29

Increased by 8 (+38%)

Debt Ratio

470%

Increased by 157 (+50%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (1)

Investor NameInvestor SinceParticipating Rounds
Investor 3Jun 2018Management Buyout

Share Capital

Share Capital

Share allotments and capital structure

20 Allotments 212,410 Shares £24k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Nov 20241,000£0£0
9 Nov 20241,000£0£0
21 Oct 20244,300£0£0
21 Oct 202460,733£0£0
21 Oct 20247,000£0£0

Officers

Officers

1 active 2 resigned
Status
Anthony Clive Garner KingDirectorBritishEngland688 Oct 2024Active

Shareholders

Shareholders (14)

Foresight Regional Investment Lp
67.4%
67,400
Catherine Booth
15.3%
15,300

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased

Foresight Regional Investment Lp

Unknown

Active
Notified 8 Jun 2018
Nature of Control
  • Ownership Of Shares 50 To 75 Percent

Catherine Booth

Ceased 8 Jun 2018

Ceased
Ceased

Genedrive Plc

Ceased 9 Jan 2018

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

3 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Dec 2025Confirmation StatementConfirmation statement made on 2025-10-24 with updates
2 Dec 2025OfficersAppointment of Ms Aude-Marine Bonavita as director on 2025-12-01
28 Aug 2025OfficersTermination of Andrew Milnes as director on 2025-08-28
13 Jun 2025ResolutionResolutions
13 Jun 2025ResolutionResolutions
11 Dec 2025 Confirmation Statement

Confirmation statement made on 2025-10-24 with updates

2 Dec 2025 Officers

Appointment of Ms Aude-Marine Bonavita as director on 2025-12-01

28 Aug 2025 Officers

Termination of Andrew Milnes as director on 2025-08-28

13 Jun 2025 Resolution

Resolutions

13 Jun 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Confirmation statement made on 2025-10-24 with updates

4 months ago on 11 Dec 2025

Appointment of Ms Aude-Marine Bonavita as director on 2025-12-01

4 months ago on 2 Dec 2025

Termination of Andrew Milnes as director on 2025-08-28

7 months ago on 28 Aug 2025

Resolutions

10 months ago on 13 Jun 2025

Resolutions

10 months ago on 13 Jun 2025